KD Logo

CRL (Charles River Laboratories International Inc.) may reap gains as insiders became active recently

Charles River Laboratories International Inc.’s recently made public that its Director MASSARO GEORGE unloaded Company’s shares for reported $78225.0 on May 15 ’24. In the deal valued at $235.62 per share,332 shares were sold. As a result of this transaction, MASSARO GEORGE now holds 5,855 shares worth roughly $1.18 million.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Then, LaPlume Joseph W sold 1,304 shares, generating $295,969 in total proceeds. Upon selling the shares at $226.97, the EVP, Corp Strategy & Develop now owns 23,276 shares.

Before that, Knell Michael Gunnar sold 808 shares. Charles River Laboratories International Inc. shares valued at $216,156 were divested by the CSVP&Chief Accounting Officer at a price of $267.52 per share. As a result of the transaction, Knell Michael Gunnar now holds 7,024 shares, worth roughly $1.42 million.

Argus downgraded its Charles River Laboratories International Inc. [CRL] rating to a Hold from a a Buy in a research note published recently. A number of analysts have revised their coverage, including Mizuho’s analysts, who began to cover the stock in early June with a ‘”a Neutral”‘ rating. Goldman began covering CRL with “Buy” recommendation on June 06, 2024. Guggenheim revised its rating on February 15, 2024. It rated CRL as “a Neutral” which previously was an “a Buy”.

Price Performance Review of CRL

On Tuesday, Charles River Laboratories International Inc. [NYSE:CRL] saw its stock fall -0.87% to $201.48. Over the last five days, the stock has lost -2.38%. Charles River Laboratories International Inc. shares have fallen nearly -14.77% since the year began. Nevertheless, the stocks have fallen -4.17% over the past one year. While a 52-week high of $275.00 was reached on 03/08/24, a 52-week low of $161.65 was recorded on 01/17/24. SMA at 50 days reached $219.72, while 200 days put it at $219.24. A total of 0.44 million shares were traded, compared to the trading of 0.42 million shares in the previous session.

Levels Of Support And Resistance For CRL Stock

The 24-hour chart illustrates a support level at 200.35, which if violated will result in even more drops to 199.21. On the upside, there is a resistance level at 203.36. A further resistance level may holdings at 205.23. The Relative Strength Index (RSI) on the 14-day chart is 31.30, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -4.58, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 97.58%. Stochastics%K at 9.64% indicates the stock is a buying.

The most recent change occurred on September 13, 2023 when TD Cowen began covering the stock and recommended ‘”a Market perform”‘ rating along with a $212 price target.

Most Popular